Search

everythinglearnresearchcommunity

for

Search:↓

Radiation-induced hair loss may be caused by hair growth stopping and inflammation in blood vessels.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Retinoic acid affects male and female muscle energy use and function differently.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Inositol helped cure hair loss around rats' eyes and improved their growth.

Radioiodine-131 significantly accumulates in skin and hair.

Targeting the AhR pathway may help treat alopecia areata.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Low-level laser therapy can significantly regrow hair in alopecia areata.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.